• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

BMS-536924

CAS No. 468740-43-4

BMS-536924 ( BMS536924; BMS-536924; BMS 536924 )

产品货号. M17514 CAS No. 468740-43-4

BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2.

纯度: 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥599 有现货
10MG ¥1045 有现货
25MG ¥2090 有现货
50MG ¥4010 有现货
100MG ¥5370 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    BMS-536924
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1/2.
  • 产品描述
    BMS-536924 is a potent small molecule inhibitor of IGF-IR, which shows antitumor activity in multiple tumor models, including sarcoma.
  • 同义词
    BMS536924; BMS-536924; BMS 536924
  • 通路
    Others
  • 靶点
    Other Targets
  • 受体
    FAK; IGF-1R; Insulin Receptor; MEK; Lck
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    468740-43-4
  • 分子量
    479.96
  • 分子式
    C25H26ClN5O3
  • 纯度
    98%
  • 溶解度
    DMSO : 50 mg/mL. 104.18 mM; H2O : < 0.1 mg/mL
  • SMILES
    CC1=C2N=C(NC2=CC(=C1)N1CCOCC1)C1=C(NC[C@@H](O)C2=CC=CC(Cl)=C2)C=CNC1=O
  • 化学全称
    (S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Wittman M, et al. J Med Chem, 2005, 48(18), 5639-5643.
产品手册
关联产品
  • PACAP-38 (16-38), hu...

    PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production.

  • Scabertopin

    Scabertopin has a significant antitumor effect in vitro in a concentration-dependent manner. It is isolated from the whole plant of Elephantopus scaber.

  • Uprosertib

    Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2.